Update to U.S. Selected Practice Rec.for Contraceptive Use: Self-Administration of Subcutaneous Depot Medroxyprogesterone Acetate

Curtis, Kathryn M.; Nguyen, Antoinette; Reeves, Jennifer A.; Clark, Elizabeth A.; Folger, Suzanne G.; Whiteman, Maura K.

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Update to U.S. Selected Practice Rec.for Contraceptive Use: Self-Administration of Subcutaneous Depot Medroxyprogesterone Acetate

May 21 2021
By Curtis, Kathryn M. ; Nguyen, Antoinette ; Reeves, Jennifer A. ; ...
Source: MMWR Morb Mortal Wkly Rep. 70(20):739-743

[PDF-95.05 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

MMWR Morb Mortal Wkly Rep
Personal Author:

Curtis, Kathryn M. ; Nguyen, Antoinette ; Reeves, Jennifer A. ; Clark, Elizabeth A. ; Folger, Suzanne G. ; ... More +

Curtis, Kathryn M. ; Nguyen, Antoinette ; Reeves, Jennifer A. ; Clark, Elizabeth A. ; Folger, Suzanne G. ; Whiteman, Maura K. Less -
Description:

U.S. Selected Practice Rec.for Contraceptive Use (U.S. SPR), adapted by CDC from global guidance developed by the World Health Organization (WHO), provides evidence-based guidance on contraceptive use for U.S. health care providers (1). During January-February, 2021, CDC evaluated the 2019 WHO recommendation on self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) (2). CDC adopted the WHO recommendation on the basis of moderate-certainty evidence that self-administered DMPA-SC is safe and effective, and has higher continuation rates compared with provider-administered DMPA. The new U.S. SPR recommendation states that self-administered DMPA-SC should be made available as an additional approach to deliver injectable contraception. Provider-administered DMPA should remain available. Self-administered DMPA-SC is a user-controlled method that has the potential to improve contraceptive access and increase reproductive autonomy. Self-administered DMPA-SC should be offered in a noncoercive manner through a shared decision-making process between patients and their health care providers, with a focus on patient preferences and equitable access to the full range of contraceptive Methods.
Subjects:

[+]

Contraceptive Agents, Female Female Humans Injections, Subcutaneous Medroxyprogesterone Acetate Self Administration
Source:

MMWR Morb Mortal Wkly Rep. 70(20):739-743
Pubmed ID:

34014910
Pubmed Central ID:

PMC8136426
Document Type:

Journal Article
Name as Subject:

Centers for Disease Control and Prevention (U.S.) ; Centers for Disease Control and Prevention (U.S.)

Centers for Disease Control and Prevention (U.S.) ; Centers for Disease Control and Prevention (U.S.) Less -
Place as Subject:

U.S.
Collection(s):

Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:

[+]

urn:sha256:28b7906e861681130eb5c7977898dc4750138ac7a1aba47e9613745d602cc9c6
Download URL:

https://stacks.cdc.gov/view/cdc/106673/cdc_106673_DS1.pdf
File Type:

mm7020a2.nxml

xml

More +